GeneDx Holdings (WGS) Inventory Average (2021 - 2026)

GeneDx Holdings (WGS) has reported Inventory Average for 6 consecutive years, with $15.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 22.23% year-over-year to $15.0 million in Q2 2026; TTM through Jun 2026 was $15.0 million, a 22.23% increase from a year earlier, with the FY2025 full-year figure at $12.3 million, up 26.63% from the prior year.
• Inventory Average was $15.0 million for Q2 2026 at GeneDx Holdings, up from $13.1 million in the prior quarter.
• Over five years, Inventory Average peaked at $42.9 million in Q3 2022 and troughed at $9.1 million in Q4 2023.
• A 5-year average of $17.1 million and a median of $12.1 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average soared 42.24% in 2022 and sank 75.66% in 2023, its largest moves.
• Over 5 years, Inventory Average stood at $28.9 million in 2022, then tumbled by 68.66% to $9.1 million in 2023, then gained by 18.17% to $10.7 million in 2024, then gained by 14.47% to $12.3 million in 2025, then climbed by 22.6% to $15.0 million in 2026.
• The last three Inventory Average figures came in at $15.0 million (Q2 2026), $13.1 million (Q1 2026), and $12.3 million (Q4 2025), per Business Quant data.